Searching for new markers in age-related eye diseases
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study looks for proteins in the blood and eye fluids that may help doctors better understand and monitor three common eye conditions: age-related macular degeneration, diabetic retinopathy, and retinal detachment. If you have one of these conditions, or if you are a healthy control with no retinal disease, you may be able to help by giving a small sample of blood or fluid from your eye during a routine procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to understand the study and give your permission (informed consent).
- You are willing to follow the study schedule and procedures.
- For patients in the study: you have age-related macular degeneration (intermediate or advanced), diabetic retinopathy, or are having surgery for a detached retina.
- For people in the control group: you are having cataract surgery and have no known retinal disease, or you are an outpatient without retinal problems.
- You cannot have an active eye infection or certain blood protein abnormalities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special eye scan to take detailed pictures of the back of the eye in people with various retinal conditions. It may help doctors better understand and manage these diseases.
This study collects samples like blood and a small skin biopsy (and sometimes urine, hair, or saliva) to better understand causes of eye diseases. The goal is to study eye conditions and may help researchers build better tests or treatments.
This study looks at substances (“biomarkers”) in the clear fluid inside the eye to better understand several eye conditions that affect vision. Your results may help doctors learn how these diseases work and how treatments might be chosen.
This study collects immune cells (from a blood sample) from people with certain types of age-related macular degeneration (AMD) and compares how long they live. It may help researchers understand how immune-related changes relate to AMD outcomes.
This study collects and stores blood and eye-related medical information to help researchers better understand retinal diseases, including age-related macular degeneration and diabetic retinopathy. Your samples may also be used to compare people with retinal disease to people without it.
This study looks at a specific lab marker (sCD160) in blood and eye fluids to see how it relates to poor blood flow in the retina. You may be asked for samples taken during eye surgery to help doctors understand the disease better.
Hear when a new Retinal Detachment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.